Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Neoplasia. [Review]

Antireflux and Endoscopic Therapies for Barrett Esophagus and Superficial Esophageal Neoplasia. [Review] - 2021

Available online from MWHC library: 1996 - present, Available in print through MWHC library: 1999 - February 2007

Barrett esophagus (BE), defined as intestinal metaplasia of the distal esophageal mucosa, typically results from chronic gastroesophageal reflux disease and is the only known precursor of esophageal adenocarcinoma. The standard of care for the management of early esophageal neoplasia in the setting of BE has changed drastically over the past 15 years. Further investigation into diagnostic and therapeutic adjuncts will continue to improve our ability to control or cure BE before its advancement to a life-threatening malignancy. Copyright (c) 2021 Elsevier Inc. All rights reserved.


English

0039-6109

10.1016/j.suc.2021.03.002 [doi] S0039-6109(21)00014-1 [pii]


IN PROCESS -- NOT YET INDEXED


MedStar Franklin Square Medical Center
MedStar Washington Hospital Center


General Surgery Residency
Surgery/General Surgery


Journal Article
Review

Powered by Koha